Article Versions Notes

Li S-H, Wu M-H, Wang H-M, Hsu P-C, Fang Y-F, Wang C-L, Chu H-C, Lin H-C, Lee L-Y, Wu C-Y, et al. Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study. International Journal of Molecular Sciences. 2022; 23(18):10661. https://doi.org/10.3390/ijms231810661

Li, Shih-Hong, Min-Hsien Wu, Hung-Ming Wang, Ping-Chih Hsu, Yueh-Fu Fang, Chih-Liang Wang, Hui-Chun Chu, Hung-Chih Lin, Li-Yu Lee, Ching-Yang Wu, and et al. 2022. "Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study" International Journal of Molecular Sciences 23, no. 18: 10661. https://doi.org/10.3390/ijms231810661

Li, S.-H., Wu, M.-H., Wang, H.-M., Hsu, P.-C., Fang, Y.-F., Wang, C.-L., Chu, H.-C., Lin, H.-C., Lee, L.-Y., Wu, C.-Y., Yang, C.-T., Chen, J.-S., & Hsieh, J. C.-H. (2022). Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study. International Journal of Molecular Sciences, 23(18), 10661. https://doi.org/10.3390/ijms231810661